|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang X, Chen BB, Zhang MH and Wang XR:
MicroRNA-126 inhibits the proliferation of lung cancer cell line
A549. Asian Pac J Trop Med. 8:239–242. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peters S, Adjei AA, Gridelli C, Reck M,
Kerr K and Felip E: ESMO Guidelines Working Group: Metastatic
non-small-cell lung cancer (NSCLC): ESMO clinical practice
guidelines for diagnosis, treatment and follow-up. Ann Oncol. 23
Suppl 7:vii56–vii64. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang S, Zhang Y, Zhao X, Wang J and Shang
J: microRNA-361 targets Wilms' tumor 1 to inhibit the growth,
migration and invasion of non-small-cell lung cancer cells. Mol Med
Rep. 14:5415–5421. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen C, Zhao Z, Liu Y and Mu D:
microRNA-99a is downregulated and promotes proliferation, migration
and invasion in non-small cell lung cancer A549 and H1299 cells.
Oncol Lett. 9:1128–1134. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang H, Zhang H, Hu X and Li W: Knockdown
of long non-coding RNA XIST inhibits cell viability and invasion by
regulating miR-137/PXN axis in non-small cell lung cancer. Int J
Biol Macromol. 111:623–631. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lei T, Zhu Y, Jiang C, Wang Y, Fu J, Fan Z
and Qin H: MicroRNA-320 was downregulated in non-small cell lung
cancer and inhibited cell proliferation, migration and invasion by
targeting fatty acid synthase. Mol Med Rep. 14:1255–1262. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cui Y, Chen LG, Yao HB, Zhang J and Ding
KF: Upregulation of microRNA-383 inhibits the proliferation,
migration and invasion of colon cancer cells. Oncol Lett.
15:1184–1190. 2018.PubMed/NCBI
|
|
10
|
Xia D, Li X, Niu Q, Liu X, Xu W, Ma C, Gu
H, Liu Z, Shi L, Tian X, et al: MicroRNA-185 suppresses pancreatic
cell proliferation by targeting transcriptional coactivator with
PDZ-binding motif in pancreatic cancer. Exp Ther Med. 15:657–666.
2018.PubMed/NCBI
|
|
11
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Anninos P, Chatzimichael A, Adamopoulos A,
Kotini A and Tsagas N: A combined study of MEG and pico-Tesla TMS
on children with autism disorder. J Integra Neurosci. 15:497–513.
2016. View Article : Google Scholar
|
|
14
|
Olbromski M, Grzegrzolka J,
Jankowska-Konsur A, Witkiewicz W, Podhorska-Okolow M and Dziegiel
P: MicroRNAs modulate the expression of the SOX18 transcript in
lung squamous cell carcinoma. Oncol Rep. 36:2884–2892. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang D, Zhi T, Xu X, Bao Z, Fan L, Li Z,
Ji J and Liu N: MicroRNA-936 induces cell cycle arrest and inhibits
glioma cell proliferation by targeting CKS1. Am J Cancer Res.
7:2131–2143. 2017.PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang D, Cao Q, Qu M, Xiao Z, Zhang M and
Di S: MicroRNA-616 promotes the growth and metastasis of non-small
cell lung cancer by targeting SOX7. Oncol Rep. 38:2078–2086. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu GW, Qin ZM and Shen QH: An ensemble
method integrated with miRNA expression data for predicting miRNA
targets in stomach adenocarcinoma. Cancer Biomark. 20:617–625.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu S, Suo J, Wang C, Sun X, Wang D, He L,
Zhang Y and Li W: Prognostic significance of low miR-144 expression
in gastric cancer. Cancer Biomark. 20:547–552. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mei LL, Qiu YT, Huang MB, Wang WJ, Bai J
and Shi ZZ: miR-99a suppresses proliferation, migration and
invasion of esophageal squamous cell carcinoma cells through
inhibiting the IGF1R signaling pathway. Cancer Biomark. 20:527–537.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Krishnan AR, Zheng H, Kwok JG, Qu Y, Zou
AE, Korrapati A, Li PX, Califano JA, Hovell MF, Wang-Rodriguez J
and Ongkeko WM: A comprehensive study of smoking-specific microRNA
alterations in head and neck squamous cell carcinoma. Oral Oncol.
72:56–64. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ou L, Wang D, Zhang H, Yu Q and Hua F:
Decreased expression of miR-138-5p by LncRNA H19 in cervical cancer
promotes tumor proliferation. Oncol Res. Aug 10–2017.(Epub ahead of
print). View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dong Y, Liu Y, Jiang A, Li R, Yin M and
Wang Y: MicroRNA-335 suppresses the proliferation, migration, and
invasion of breast cancer cells by targeting EphA4. Mol Cell
Biochem. 439:95–104. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang L, Peng F, Qin J, Zhou H and Wang B:
Downregulation of microRNA-196a inhibits human liver cancer cell
proliferation and invasion by targeting FOXO1. Oncol Rep.
38:2148–2154. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ling DJ, Chen ZS, Zhang YD, Liao QD, Feng
JX, Zhang XY and Shi TS: MicroRNA-145 inhibits lung cancer cell
metastasis. Mol Med Rep. 11:3108–3114. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang L, Feng G, Zhang X, Ding Y and Wang
X: microRNA630 promotes cell proliferation and inhibits apoptosis
in the HCT116 human colorectal cancer cell line. Mol Med Rep.
16:4843–4848. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu C, Liu Z, Li X, Tang X, He J and Lu S:
MicroRNA-1297 contributes to tumor growth of human breast cancer by
targeting PTEN/PI3K/AKT signaling. Oncol Rep. 38:2435–2443. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Feliciano A, Garcia-Mayea Y, Jubierre L,
Mir C, Hummel M, Castellvi J, Hernández-Losa J, Paciucci R, Sansano
I, Sun Y, et al: miR-99a reveals two novel oncogenic proteins E2F2
and EMR2 and represses stemness in lung cancer. Cell Death Dis.
8:e31412017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tao T, Shen Q, Luo J, Xu Y and Liang W:
MicroRNA-125a Regulates cell proliferation via directly targeting
E2F2 in osteosarcoma. Cell Physiol Biochem. 43:768–774. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao H, Tang W, Chen X, Wang S, Wang X, Xu
H and Li L: The NAMPT/E2F2/SIRT1 axis promotes proliferation and
inhibits p53-dependent apoptosis in human melanoma cells. Biochem
Biophys Res Commun. 493:77–84. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xie L, Li T and Yang LH: E2F2 induces
MCM4, CCNE2 and WHSC1 upregulation in ovarian cancer and predicts
poor overall survival. Eur Rev Med Pharmacol Sci. 21:2150–2156.
2017.PubMed/NCBI
|
|
32
|
Song H, Zhang Y, Liu N, Zhang D, Wan C,
Zhao S, Kong Y and Yuan L: Let-7b inhibits the malignant behavior
of glioma cells and glioma stem-like cells via downregulation of
E2F2. J Physiol Biochem. 72:733–744. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang H, Zhang X, Liu Y, Ni Z, Lin Y, Duan
Z, Shi Y, Wang G and Li F: Downregulated miR-31 level associates
with poor prognosis of gastric cancer and its restoration
suppresses tumor cell malignant phenotypes by inhibiting E2F2.
Oncotarget. 7:36577–36589. 2016.PubMed/NCBI
|
